Design and implementation of a national SARS-CoV-2 monitoring program in England: REACT-1 Study
<p><strong>Data System:</strong> The REal-time Assessment of Community Transmission-1 (REACT-1) Study was funded by the Department of Health and Social Care in England to provide reliable and timely estimates of prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-Co...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American Public Health Association
2023
|
| _version_ | 1797109215375917056 |
|---|---|
| author | Elliott, P Whitaker, M Tang, D Eales, O Steyn, N Bodinier, B Wang, H Elliott, J Atchison, C Ashby, D Barclay, W Taylor, G Darzi, A Cooke, G Ward, H Donnelly, C Riley, S Chadeau-Hyam, M |
| author_facet | Elliott, P Whitaker, M Tang, D Eales, O Steyn, N Bodinier, B Wang, H Elliott, J Atchison, C Ashby, D Barclay, W Taylor, G Darzi, A Cooke, G Ward, H Donnelly, C Riley, S Chadeau-Hyam, M |
| author_sort | Elliott, P |
| collection | OXFORD |
| description | <p><strong>Data System:</strong> The REal-time Assessment of Community Transmission-1 (REACT-1) Study was funded by the Department of Health and Social Care in England to provide reliable and timely estimates of prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection over time, by person and place.</p>
<p><strong>Data Collection/Processing:</strong> The study team (researchers from Imperial College London and its logistics partner Ipsos) wrote to named individuals aged 5 years and older in random cross-sections of the population of England, using the National Health Service list of patients registered with a general practitioner (near-universal coverage) as a sampling frame. We collected data over 2 to 3 weeks approximately every month across 19 rounds of data collection from May 1, 2020, to March 31, 2022.</p>
<p><strong>Data Analysis/Dissemination:</strong> We have disseminated the data and study materials widely via the study Web site, preprints, publications in peer-reviewed journals, and the media. We make available data tabulations, suitably anonymized to protect participant confidentiality, on request to the study’s data access committee.</p>
<p><strong>Public Health Implications:</strong> The study provided inter alia real-time data on SARS-CoV-2 prevalence over time, by area, and by sociodemographic variables; estimates of vaccine effectiveness; and symptom profiles, and detected emergence of new variants based on viral genome sequencing.</p> |
| first_indexed | 2024-03-07T07:38:47Z |
| format | Journal article |
| id | oxford-uuid:007b0f94-49aa-4b0d-81b9-2f84ea7f1244 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:38:47Z |
| publishDate | 2023 |
| publisher | American Public Health Association |
| record_format | dspace |
| spelling | oxford-uuid:007b0f94-49aa-4b0d-81b9-2f84ea7f12442023-04-06T15:25:18ZDesign and implementation of a national SARS-CoV-2 monitoring program in England: REACT-1 StudyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:007b0f94-49aa-4b0d-81b9-2f84ea7f1244EnglishSymplectic ElementsAmerican Public Health Association2023Elliott, PWhitaker, MTang, DEales, OSteyn, NBodinier, BWang, HElliott, JAtchison, CAshby, DBarclay, WTaylor, GDarzi, ACooke, GWard, HDonnelly, CRiley, SChadeau-Hyam, M<p><strong>Data System:</strong> The REal-time Assessment of Community Transmission-1 (REACT-1) Study was funded by the Department of Health and Social Care in England to provide reliable and timely estimates of prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection over time, by person and place.</p> <p><strong>Data Collection/Processing:</strong> The study team (researchers from Imperial College London and its logistics partner Ipsos) wrote to named individuals aged 5 years and older in random cross-sections of the population of England, using the National Health Service list of patients registered with a general practitioner (near-universal coverage) as a sampling frame. We collected data over 2 to 3 weeks approximately every month across 19 rounds of data collection from May 1, 2020, to March 31, 2022.</p> <p><strong>Data Analysis/Dissemination:</strong> We have disseminated the data and study materials widely via the study Web site, preprints, publications in peer-reviewed journals, and the media. We make available data tabulations, suitably anonymized to protect participant confidentiality, on request to the study’s data access committee.</p> <p><strong>Public Health Implications:</strong> The study provided inter alia real-time data on SARS-CoV-2 prevalence over time, by area, and by sociodemographic variables; estimates of vaccine effectiveness; and symptom profiles, and detected emergence of new variants based on viral genome sequencing.</p> |
| spellingShingle | Elliott, P Whitaker, M Tang, D Eales, O Steyn, N Bodinier, B Wang, H Elliott, J Atchison, C Ashby, D Barclay, W Taylor, G Darzi, A Cooke, G Ward, H Donnelly, C Riley, S Chadeau-Hyam, M Design and implementation of a national SARS-CoV-2 monitoring program in England: REACT-1 Study |
| title | Design and implementation of a national SARS-CoV-2 monitoring program in England: REACT-1 Study |
| title_full | Design and implementation of a national SARS-CoV-2 monitoring program in England: REACT-1 Study |
| title_fullStr | Design and implementation of a national SARS-CoV-2 monitoring program in England: REACT-1 Study |
| title_full_unstemmed | Design and implementation of a national SARS-CoV-2 monitoring program in England: REACT-1 Study |
| title_short | Design and implementation of a national SARS-CoV-2 monitoring program in England: REACT-1 Study |
| title_sort | design and implementation of a national sars cov 2 monitoring program in england react 1 study |
| work_keys_str_mv | AT elliottp designandimplementationofanationalsarscov2monitoringprograminenglandreact1study AT whitakerm designandimplementationofanationalsarscov2monitoringprograminenglandreact1study AT tangd designandimplementationofanationalsarscov2monitoringprograminenglandreact1study AT ealeso designandimplementationofanationalsarscov2monitoringprograminenglandreact1study AT steynn designandimplementationofanationalsarscov2monitoringprograminenglandreact1study AT bodinierb designandimplementationofanationalsarscov2monitoringprograminenglandreact1study AT wangh designandimplementationofanationalsarscov2monitoringprograminenglandreact1study AT elliottj designandimplementationofanationalsarscov2monitoringprograminenglandreact1study AT atchisonc designandimplementationofanationalsarscov2monitoringprograminenglandreact1study AT ashbyd designandimplementationofanationalsarscov2monitoringprograminenglandreact1study AT barclayw designandimplementationofanationalsarscov2monitoringprograminenglandreact1study AT taylorg designandimplementationofanationalsarscov2monitoringprograminenglandreact1study AT darzia designandimplementationofanationalsarscov2monitoringprograminenglandreact1study AT cookeg designandimplementationofanationalsarscov2monitoringprograminenglandreact1study AT wardh designandimplementationofanationalsarscov2monitoringprograminenglandreact1study AT donnellyc designandimplementationofanationalsarscov2monitoringprograminenglandreact1study AT rileys designandimplementationofanationalsarscov2monitoringprograminenglandreact1study AT chadeauhyamm designandimplementationofanationalsarscov2monitoringprograminenglandreact1study |